273
Views
0
CrossRef citations to date
0
Altmetric
Commentary

Tumor Immune Microenvironment of EGFR-mutant Non-Small-Cell Lung Cancer and its Impact on Therapeutic Efficacy

&
Pages 431-437 | Received 04 Dec 2019, Accepted 08 Apr 2020, Published online: 22 Apr 2020
 

Financial & competing interests disclosure

Y Koh receives honoraria from AstraZeneca, Chugai Pharmaceutical and Boehringer Ingelheim. The research presented in this article received funding from AstraZeneca, Chugai Pharmaceutical, Boehringer Ingelheim, Bristol Myers Squibb and Ono Pharmaceutical. The author have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Additional information

Funding

Y Koh receives honoraria from AstraZeneca, Chugai Pharmaceutical and Boehringer Ingelheim. The research presented in this article received funding from AstraZeneca, Chugai Pharmaceutical, Boehringer Ingelheim, Bristol Myers Squibb and Ono Pharmaceutical. The author have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.